AS
TEVA icon

Altshuler Shaham’s Teva Pharmaceuticals TEVA Stock Holding History

Altshuler Shaham’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$412M Buy
12,466,895
+1,003,274
+9% +$33.4M 5.12% 2
2026
Q1 		$335M Buy
11,463,621
+2,969,500
+35% +$95.5M 6.04% 3
2025
Q4 		$269M Buy
8,494,121
+196,697
+2% +$4.85M 4.08% 6
2025
Q3 		$162M Buy
8,297,424
+7,443,267
+871% +$131M 2.68% 14
2025
Q2 		$14.3M Buy
854,157
+159,580
+23% +$2.58M 0.46% 22
2025
Q1 		$10.6M Buy
694,577
+498,314
+254% +$8.9M 0.26% 22
2024
Q4 		$4.36M Sell
196,263
-25,267
-11% -$460K 0.15% 26
2024
Q3 		$3.96M Sell
221,530
-56,390
-20% -$987K 0.24% 23
2024
Q2 		$4.52M Buy
277,920
+30,530
+12% +$470K 0.15% 21
2024
Q1 		$3.48M Buy
247,390
+122,709
+98% +$1.55M 0.14% 16
2023
Q4 		$1.31M Sell
124,681
-35,149
-22% -$328K 0.07% 33
2023
Q3 		$1.61M Sell
159,830
-151,035
-49% -$1.41M 0.04% 35
2023
Q2 		$2.35M Sell
310,865
-5,517
-2% -$44.7K 0.04% 31
2023
Q1 		$2.8M Buy
316,382
+236,432
+296% +$2.34M 0.06% 27
2022
Q4 		$750K Buy
+79,950
New +$698K 0.03% 48
2021
Q3 		– Sell
-1,320
Closed -$13K – 658
2021
Q2 		$13K Buy
+1,320
New +$14K ﹤0.01% 535
2020
Q2 		– Sell
-45
Closed – – 555
2020
Q1 		$0 Hold
45
– – ﹤0.01% 604
2019
Q4 		$0 Buy
+45
New +$402 ﹤0.01% 614
2018
Q1 		– Sell
-29,031
Closed -$567K – 225
2017
Q4 		$506K Buy
+29,031
New +$437K 0.07% 84

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Altshuler Shaham's TEVA Position: Q2 2026 in Review

Altshuler Shaham increased its Teva Pharmaceuticals (TEVA) stake by 8.8% in Q2 2026, buying an estimated $33.4M and bringing the position to 12,466,895 shares worth $412M. The position accounts for 5.12% of the portfolio, ranked #2.

Altshuler Shaham first reported a position in TEVA in Q4 2017 and has held it in 19 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Altshuler Shaham held 12,466,895 shares of Teva Pharmaceuticals worth $412M as of Q2 2026.
  • Altshuler Shaham bought 1,003,274 Teva Pharmaceuticals shares in Q2 2026, an estimated $33.4M.
  • Teva Pharmaceuticals made up 5.12% of Altshuler Shaham's portfolio in Q2 2026, its #2 holding.
  • Altshuler Shaham first reported a position in Teva Pharmaceuticals in Q4 2017 and has held it in 19 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Altshuler Shaham's 13F filing for Q2 2026, filed 12 Aug 2026.